|
CUL4A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.79489999991334E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.04499999999697E-05 |
| Normal-vs-Stage2 |
2.335700E-02 |
| Normal-vs-Stage3 |
3.01170000005513E-06 |
| Normal-vs-Stage4 |
2.07869999999666E-05 |
| Stage1-vs-Stage2 |
6.028400E-01 |
| Stage1-vs-Stage3 |
3.218000E-01 |
| Stage1-vs-Stage4 |
4.847600E-01 |
| Stage2-vs-Stage3 |
3.038800E-01 |
| Stage2-vs-Stage4 |
3.484400E-01 |
| Stage3-vs-Stage4 |
9.517600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.33389999998646E-07 |
| Normal-vs-AfricanAmerican |
1.411410E-01 |
| Normal-vs-Asian |
9.52300000000017E-05 |
| Caucasian-vs-AfricanAmerican |
9.945600E-02 |
| Caucasian-vs-Asian |
8.204200E-01 |
| AfricanAmerican-vs-Asian |
1.018990E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.77220000000733E-05 |
| Normal-vs-Female |
1.0920999999886E-06 |
| Male-vs-Female |
9.810200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.72730000000243E-05 |
| Normal-vs-Age(41-60Yrs) |
1.84173999999704E-05 |
| Normal-vs-Age(61-80Yrs) |
1.3251999999575E-06 |
| Normal-vs-Age(81-100Yrs) |
1.690120E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.593400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.173000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.506200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.372800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.314000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.996600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.421000E-01 |
| Classical-VS-Follicular |
5.980600E-01 |
| Classical-VS-Other |
4.477800E-01 |
| Classical-VS-Normal |
1.155300E-04 |
| Tall-VS-Follicular |
6.416400E-01 |
| Tall-VS-Other |
7.880800E-01 |
| Tall-VS-Normal |
4.011100E-04 |
| Follicular-VS-Other |
6.732000E-01 |
| Follicular-VS-Normal |
4.994800E-04 |
| Other-VS-Normal |
1.445990E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.42690000004553E-06 |
| Normal-vs-N1 |
9.08019999967813E-07 |
| N0-vs-N1 |
2.488800E-01 |
|
|
